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It has been suggested that a conserved heptad repeat region in paramyxovirus fusion (F) proteins is essential for viral
fusion activity (Buckland et al., 1992; Sergel et al., 1994; Reitter et al., 1995). We have studied synthetic peptides containing
the heptad repeat regions derived from the F proteins of human parainfluenza virus type 2 (PI2) and type 3 (PI3) for their
function as potential inhibitors of virus-induced cell fusion as well as their effects on spread of viral infection. Two peptides
containing sequences of heptad repeat B, adjacent to the transmembrane domain of the F protein, were synthesized for
both PI2 and PI3 F proteins. We observed that the longer peptides [34 amino acids (a.a.) for PI2F or 35 a.a. for PI3F] which
extend from heptad repeat B to the transmembrane domain showed complete inhibition of cell fusion induced by the
respective virus as well as by the vaccinia-expressed F and HN proteins. The 50% effective concentration to inhibit virus-
induced cell fusion was 2.1 mM for PI2 and 1.2 mM for PI3. Moreover, the inhibitory effects of each peptide on virus-
induced cell fusion were found to be virus type-specific. These peptides were found to also inhibit viral entry and to prevent
plaque formation when mixed with the virus inoculum. Furthermore, the peptides caused a reduction in virus yield when
assayed 48 hr after low m.o.i. infection and in the size of viral plaques when added to the overlay. Shorter peptides (21 a.a.
for PI2F or 24 a.a. for PI3F) which correspond to the partial sequence of heptad repeat B for PI2F and the entire heptad
repeat B for PI3F showed partial inhibition of PI2- or PI3-induced cell fusion. These results indicate that peptides containing
the heptad repeat B sequence have the potential to inhibit virus-induced cell fusion, virus entry, and spread of virus infection.
q 1996 Academic Press, Inc.
INTRODUCTION peptide sequence is highly conserved among paramyxo-
virus F proteins (Morrison and Portner, 1991) and is con-
The human parainfluenza viruses are enveloped vi-
sidered to be directly involved in mediating membrane
ruses which possess an outer limiting membrane con-
fusion (Lamb, 1993). Two heptad repeat regions which
taining two glycoproteins, the hemagglutinin-neuramini-
have the potential to form a-helices are consistently
dase (HN) and fusion (F) proteins (Morrison and Portner,
present in the F proteins of paramyxoviruses. Heptad
1991). It was initially proposed that the HN protein pro-
repeat A lies adjacent to the hydrophobic fusion peptide
vides an attachment activity which brings the F protein
at the amino terminus of F1, while heptad repeat B lies
and the target membrane into close proximity, allowing
immediately upstream of the transmembrane region
F to reach the lipid bilayer to mediate fusion (Hsu et al.,
(Buckland and Wild, 1989; Chambers et al., 1990). The
1979). However, several lines of evidence indicate that
function of the heptad repeat region is not known but
the HN protein plays a more direct role in the induction
may related to cell fusion activity (Buckland et al., 1992).
of cell fusion (Miura et al., 1982; Heath et al., 1983; Merz
The mechanism of virus-induced membrane fusion
and Wolinsky, 1983; Shibuta et al., 1983; Gittman and
has not been well defined. Previous studies in our labora-
Loyter, 1984; Nussbaum et al., 1984; Tsurudome et al.,
tory showed that cell fusion caused by human parainflu-
1986; Waxham and Wolinsky, 1986; Portner et al., 1987;
enza virus type 2 (PI2) and type 3 (PI3) glycoproteins
Thompson and Portner, 1987), whereas the F protein is
requires coexpression of F and HN proteins from the
directly involved in virus-induced membrane fusion
same virus type, suggesting that a type-specific interac-
which is required for the penetration of the virus (Choppin
tion between the homologous F and HN plays an im-
and Compans, 1975; Choppin and Scheid, 1980). Activa-
portant role in parainfluenza virus-induced cell fusion
tion of viral fusion activity by proteolytic cleavage of the
(Hu et al., 1992). Other reports have shown similar type-
F protein results in the formation of disulfide-linked F1 –
specific interactions among paramyxovirus glycoproteins
F2 subunits and exposure of a hydrophobic fusion pep-
(Horvath et al., 1992; Cattaneo and Rose, 1993; Malvoisin
tide at the N-terminus of the F1 subunit (Homma and
and Wild, 1993; Bousse et al., 1994; Heminway et al.,
Ohuchi, 1973; Scheid and Choppin, 1974). The fusion
1994; Wild et al., 1994b). Many studies with influenza
virus have demonstrated that a conformational change
in the influenza HA protein activates its fusion activity1 To whom reprint requests should be addressed.
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upon exposure to low pH (Stegmann et al., 1987; Whar- genic viruses, such as influenza HA and retroviruses. We
have investigated the function of these F peptides aston, 1987; White and Wilson, 1987; Ruigrok et al., 1988;
Doms et al., 1990). The HA2 subunit forms an extended inhibitors of virus-induced cell fusion as well as their
effects on the spread of virus infection in cell culture.coiled coil structure at low pH, in which the location of
the fusion peptide has been rearranged to the tip of the
HA trimer (Carr and Kim, 1993; Bullough et al., 1994)). In MATERIALS AND METHODS
contrast, at neutral pH, the fusion peptides are seques-
Cells, viruses, and antibody
tered near the base of the spike where they are unable
to undergo interaction with the target membrane (Wilson CV-1, HeLa T4, LLC-MK2 , and Vero cells were main-
tained in Dulbecco’s minimal essential medium (DMEM)et al., 1981). The F protein of paramyxoviruses, like influ-
enza HA, appears to undergo a conformational change with 10% newborn calf serum (HyClone Laboratories,
Inc., Logan, UT). PI2, PI3, and SV5 viruses were obtainedupon proteolytic cleavage (Hsu et al., 1981, 1982). By
analogy with influenza HA, it has been proposed that an from the Division of Research and Resources, National
Institutes of Health (Bethesda, MD). PI2 virus wasadditional conformational change occurs in the F protein
which exposes the fusion peptide at the right time and adapted to grow on LLC-MK2 cells while PI3 and SV5
viruses were grown on Vero cell, and titers of the virusesplace (Sergel et al., 1993; Lamb, 1993). However, in para-
myxoviruses this conformational change is not activated were determined on Vero cells. Recombinant vaccinia
virus-T7 (vTF7.3) was obtained from Bernard Moss (NIH).by low pH. Several possible mechanisms for triggering
the conformational change of F protein in paramyxovi- vTF7.3 was grown on HeLa T4 cells, and titers of the
virus were determined on CV-1 cells. Rabbit anti-PI2 anti-ruses have been suggested (Lamb, 1993) including inter-
action of F with HN, its interaction with receptors, or body was described by Hu et al. (1992).
interactions mediated by cellular proteins.
Recombinant plasmidsRecent reports have indicated that apart from the fu-
sion peptide, other domains within viral fusion proteins PI2F and PI2HN cDNA genes were cloned in pGEM-3
are also important in mediating the fusion event. The and pGEM-3Zf(0) plasmids (Promega Biotech, Madison,
transmembrane and cytoplasmic domains were found WI), respectively, as described previously (Hu et al.,
to be necessary for complete fusion in influenza virus 1992). The PI3F and PI3HN cDNA clones were kindly
(Kemble et al., 1994). In a study of the cytoplasmic do- provided by Dr. Mark Galinski. These two genes were
mains of PI2 and PI3 F proteins, we found that the se- subcloned into pGEM plasmid vectors. The SV5F and
quence of PI3 F cytoplasmic domain can affect para- SV5HN cDNA clones were kindly provided by Dr. Robert
myxovirus-induced cell fusion (Yao and Compans, 1995). A. Lamb and were subcloned in pGEM plasmids.
Moreover, several studies have suggested that a leucine
zipper-like motif in the region near the transmembrane Peptide synthesis and purification
domain is necessary for syncytium formation in measles
Peptides were synthesized on a Rainin Symphony Mul-virus and Newcastle disease virus (NDV) (Buckland et
tiplex multiple peptide synthesizer (Rainin Instrumentsal., 1992; Sergel et al., 1994; Reitter et al., 1995).
Company, MA). Using standard solid-phase synthesisStudies of human immunodeficiency virus type 1 (HIV-
techniques, all peptides were acetylated at the N termi-1)-induced cell fusion suggested that a coiled-coil (leu-
nus and amidated at the C terminus. Cleavage of pep-cine zipper-like) structure may be critical for a fusion-
tides from the resin and removal of side-chain blockingrelated conformational change in gp41 (Wild et al., 1992;
groups were automatically performed on the instrumentDubay et al., 1992; Chen et al., 1993). Recent studies
with trifluoroacetic acid and scavengers (5% thioanisol,indicated that synthetic peptides corresponding to two
5% water, 2.5% ethanedithiol, 0.8 M phenol). The peptidesleucine zipper-like motifs near the fusion peptide or adja-
were then washed with 12 ml cold ether four times, dis-cent to the transmembrane domain within the envelope
solved in water, and dried under vacuum overnight. Pep-protein gp41 (TM) display various extents of anti-viral
tides were dissolved in dionized water. Peptides wereactivity (Wild et al., 1992, 1994a; Jiang et al., 1993a,b).
then purified by reverse-phase HPLC on a Microsorb-Synthetic peptides corresponding to a predicted a-heli-
MV C18 , 5-mm, 300-A column (Rainin Dynamax) using acal domain were reported to be potent inhibitors of HIV-
water:70% acetonitrile plus 30% water gradient con-1 infection and fusion. In the present study, synthetic
taining 0.1 % trifluoroacetic acid. All peptides were95%peptides derived from the PI2 and PI3 F protein were
pure by analytical reverse-phase HPLC. The identity ofstudied to further define functional domains involved in
the peptides was verified by mass spectrometry.cell fusion. The peptide sequences were based on a
highly conserved heptad repeat B region in the F protein
Cell fusion assays
which was predicted to form an extended amphipathic
a-helix (O’Shea et al., 1989) structurally analogous to Monolayers of HeLa T4 cells were infected with PI2,
PI3, or SV5 at m.o.i. of 0.1. After the virus was adsorbedthose in the fusion glycoproteins of several other fuso-
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at 377 for 1 hr, the inoculum was removed and DMEM essential for viral fusion activity (Buckland et al., 1992;
Sergel et al., 1994; Reitter et al., 1995). In order to studywith 2.5% of FBS was added to the well with or without
addition of serial dilutions of each peptide. For vaccinia the role of this region in parainfluenza virus-induced cell
fusion, synthetic peptides corresponding to the heptadexpression studies, confluent monolayers of cells were
infected with vTF7.3 at a m.o.i. of 10 and incubated at repeat B region near the transmembrane domain of the
fusion protein were synthesized. Figure 1A shows a377 for 1 hr. After removal of the inoculum, cells were
transfected with 2 mg of F and HN plasmid DNA with schematic diagram of two peptides (2F1B21 and 2F1B34)
from the PI2F sequence. 2F1B21 [21 amino acids (a.a.)]lipofectin (GIBCO-BRL, Gaithersburg, MD) in 0.5 ml of
DMEM. After 24 hr (for virus-infected cells) or 18 hr (for extends from the beginning of the transmembrane do-
main to a predicted glycosylation site in the heptad re-transfected cells) of incubation at 377 in a 5% CO2 atmo-
sphere, the formation of syncytia was compared with the peat B region, while 2F1B34 (35 a.a.) extends from the
beginning of the transmembrane domain to include theinfected or transfected cell control containing no addi-
tional peptide. Cell fusion was measured by polykaryon entire heptad repeat B region. For PI3 virus (Fig. 1B),
peptide 3F1B24 (24 a.a.) corresponds to the heptad re-formation and expressed as (number of nuclei in polykar-
yons/number of total nuclei) 1 100. Cells were counted peat B only, while 3F1B35 (35 a.a.) extends from the
beginning of the transmembrane domain to include thein five different fields under a light microscope. Dose –
response curves were also generated using this method. entire heptad repeat B region.
To determine whether these peptides have the poten-The IC50 (50% inhibitory concentration) was determined
using the Miller-Tainter method (Welkos and O’Brien, tial to inhibit virus-induced cell fusion, the extent of cell
fusion was compared at 24 hr post viral infection in in-1994).
fected cells incubated with or without the peptides. In
Plaque reduction assay HeLa T4 cells infected with PI2 virus at a m.o.i. of 0.1,
A series of two-fold dilutions of F peptides together cell fusion was reduced remarkably at 24 hr postinfection
with appropriately diluted PI2 or PI3 virus were added to when incubated with 2F1B21 peptide at a concentration
monolayers of Vero cells. After 1 hr incubation at 377, the of 80 mM or more, while cell fusion was completely inhib-
inoculum was removed and overlaid with 2% white agar ited by the 2F1B34 peptide at a concentration of 4 mM.
mixed at 1:1 ratio with 21 DMEM containing 2% FBS. Similarly, in PI3 virus-infected HeLa T4 cells, the longer
Three days after overlaying, red agar mixed at a 1:1 ratio peptide 3F1B35 completely inhibited virus-induced cell
with 21 DMEM containing 2% FBS was overlaid to stain fusion at a concentration as low as 2 mM, while the
the cells. Plaque numbers were counted 1 day after neu- shorter peptide 3F1B24 only partially inhibited cell fusion
tral red staining and recorded. The Reed-Muench method at 80 mM or more. Figures 2A and 2D show that extensive
(Welkos and O’Brien, 1994) was used to calculate the syncytia are observed in HeLa T4 cells infected with
50% inhibitory concentration for virus plaque formation. either the PI2 or PI3 virus. Syncytium formation was dra-
matically decreased in HeLa T4 cells infected with theSurface immunofluorescence
virus and then incubated with the shorter peptides
Indirect immunofluorescence was performed as de- 2F1B21 (Fig. 2B) or 3F1B24 (Fig. 2E), whereas no syncytia
scribed by Paterson et al. (1989). In general, HeLa T4 were seen in infected cells incubated with the longer
cells were grown on glass coverslips in 24-well plates peptides 2F1B34 (Fig. 2C) or 3F1B35 (Fig. 2F). These
and infected with wild-type PI2 virus as described above. results demonstrate that F peptides corresponding to the
At indicated times postinfection, cells were washed with heptad repeat B have the potential to inhibit virus-in-
ice-cold PBS three times before being fixed with 1% para- duced cell fusion. However, the heptad repeat region by
formaldehyde in PBS. Rabbit anti-PI2 antibody was added itself does not appear to be sufficient for the full inhibitory
onto cell monolayers, and cells were then incubated at activity and the extra sequences extending to the trans-
47 for 30 min. Cells were washed with ice-cold PBS three membrane domain are also important for maximum inhib-
times, and then goat anti-rabbit immunoglobulin G fluo- itory activity. The length of the peptides may also play a
rescein-conjugated antibody (Southern Biotechnology role in their inhibitory activity.
Associates, Inc., Birmingham, AL) was added and was
then incubated at 47 for 30 min. Cell surface fluorescence
Inhibition of cell fusion is virus type-specific
was examined by fluorescence microscopy with a Nikon
Optiphot microscope. To determine the specificity of the inhibition of virus-
induced cell fusion, HeLa T4 cells were infected withRESULTS
one virus type and incubated with F peptides derived
Peptides containing the F protein heptad repeat B from the F protein of another virus type. The inhibition of
inhibit virus-induced cell fusion cell fusion was observed at 24 hr postinfection. As shown
in Table 1, peptides corresponding to PI2F sequencesSeveral reports have indicated that conserved heptad
repeat regions in the paramyxoviruses fusion protein are were found to inhibit only cell fusion induced by PI2 but
AID VY 8092 / 6a1d$$$161 08-05-96 14:08:35 vira AP: Virology
106 YAO AND COMPANS
FIG. 1. Schematic diagram of the F proteins of PI2 and PI3 viruses and amino acid sequences of the synthetic F peptides. (A) Full-length PI2F
and amino acid sequences of peptides 2F1B21 and 2F1B34 are shown; (ò ) represents a predicted glycosylation site within the heptad repeat B
region. Arrows represent cleavage sites. TM, transmembrane domain. (B) Full-length PI3F and amino acid sequences of peptides 3F1B24 and
3F1B35 are shown.
not PI3. Similarly, peptides from PI3F were found to in- F plus PI2 HN and 3F1B35 (at a concentration of 8 mM )
inhibited fusion by PI3 F plus PI3 HN, respectively, whilehibit only cell fusion induced by PI3 but not PI2 virus. In
addition, none of the peptides from PI2 or PI3 were found 2F1B21 and 3F1B24 only partially inhibited cell fusion.
These results indicate that peptides corresponding toto inhibit cell fusion induced by SV5. These results dem-
onstrate that the presence of a heptad repeat region, heptad repeat B have the potential to inhibit virus-in-
duced cell fusion by interfering with the activity of thewhich is predicted to form an extended a-helical struc-
ture, is not the only requirement for inhibitory activity, but viral glycoproteins in the fusion process.
that the specific amino acid sequences within heptad Inhibition of cell fusion is dose-dependent
repeat B and adjacent sequences in the peptides for
To determine the dose dependence of inhibition ofeach virus type play an essential role in the inhibitory
cell fusion, increasing concentrations of peptides wereactivity of the F peptides.
added to the culture medium and the effect on cell fusion
was determined. Figure 3 shows the dose responsePeptides derived from the F protein inhibit cell fusion
curves for the longer peptides 2F1B34 from PI2F andby vaccinia-T7-expressed F and HN proteins
3F1B35 from PI3F. At a concentration of 2 mM, peptide
In order to confirm that the F peptides inhibit cell fusion 2F1B34 was found to block about 50% of cell fusion, and
by an effect on viral glycoproteins and that they are not fusion was completely blocked by increasing the peptide
acting on other steps in the viral replication cycle, the concentration to 4 mM. Peptide 3F1B35 was found to
vaccinia-T7 transient expression system was used to ex- completely inhibit cell fusion at a concentration of as
press homologous F and HN with or without addition of low as 2 mM. Using the Miller-Tainter method, the 50%
the inhibitory peptides in the culture media. In Table 2, inhibitory concentration for cell fusion (IC50) was deter-
HeLa T4 cells were infected with recombinant vTF7.3 mined to be 2.1 mM for 2F1B34 and 1.2 mM for 3F1B35.
and then transfected with homotypic F and HN genes. The shorter peptides 2F1B21 from PI2 and 3F1B24 from
Six hours posttransfection, F peptides were added to the PI3 could only partially inhibit cell fusion even at peptide
culture media. Inhibition of F- and HN-induced cell fusion concentrations as high as 80 mM (data not shown).
was observed at 18 hr in the wells incubated with the F
F peptides inhibit viral entry and spreadpeptides. Similar to results obtained with virus infection,
2F1B34 (at a concentration of 16 mM ) was found to com- To determine whether the F peptides interfere with
the viral entry process, a plaque reduction assay waspletely inhibit cell fusion induced by coexpression of PI2
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FIG. 2. Inhibition of cell fusion by F peptides. HeLa T4 cells were infected with PI2 or PI3 virus at a m.o.i. of 0.1. After incubation of 1 hr at 377,
the inoculum was removed and DMEM with 2.5% FBS was added with or without addition of each peptide. Cells are shown at 24 hr postinfection.
(A –C) Cells were infected with PI2 virus; (D–F) cells were infected with PI3 virus. (A and D) 2.5% DMEM only; (B) addition of 80 mM of 2F1B21; (C)
4 mM of 2F1B34; (E) 80 mM of 3F1B24; (F) 2 mM of 3F1B35.
performed by inoculating cells with virus and peptide We also compared viral titers in the culture superna-
tant incubated postinfection at a m.o.i. of 0.1 with ortogether at 377 for 1 hr and then overlaying with agar
without the addition of peptide. As shown in Table 3, a without peptides in the culture media. The virus titers
were not remarkably reduced in the supernatant of cellsprogressive reduction in the number of viral plaques was
observed with increasing concentration of peptide in the incubated with the peptide at 18 or 24 hr postinfection,
indicating that the peptides do not affect the first round ofvirus inoculum. Using this method, the IC50 of F peptides
for plaque formation was determined to be 5.1 mM for virus replication when added after virus entry. However, a
15-fold decrease in the viral titer was observed at 48 hr2F1B34 and 2.2 mM for 3F1B35. These data indicate that
the F peptides inhibit the viral entry process. post PI2 infection in the presence of 2F1B34 (Fig. 4).
TABLE 1
Inhibition of Virus-Induced Cell Fusion by the F Peptides Is Virus Type-specifica
2F1B21 2F1B34 3F1B24 3F1B35
Viruses / 0 / 0 / 0 / 0
PI2 / ///b 0 /// /// /// /// ///
PI3 /// /// /// /// / /// 0 ///
SV5 /// /// /// /// /// /// /// ///
a Hela-T4 cells were infected with PI2 or PI3 at a m.o.i of 0.1. After virus adsorbtion at 377 for 1 hr, the inoculum was removed and replenished
with 2.5% DMEM with (/) or without (0) addition of peptides. Cell fusion extent was observed 24 hr postinfection.
b (///)  60% of nuclei are present in syncytia; (/) 20% of nuclei are present in syncytia; (0) no syncytia were seen.
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TABLE 2
Inhibition of Cell Fusion Induced by Vaccinia-Expressed F and HN Proteinsa by the F Peptides
2F1B21 2F1B34 3F1B24 3F1B35
Plasmids / 0 / 0 / 0 / 0
PI2F / PI2HN / ///b 0 /// /// /// /// ///
PI3F / PI3HN /// /// /// /// / /// 0 ///
SV5F / SV5HN /// /// /// /// /// /// /// ///
a Hela T4 cells were infected with vTF7.3 at a m.o.i. of 10 at 377 for 1 hr, and then cells were transfected with homologous F and HN genes. Six
hours posttransfection, F peptides were added to the culture media. Inhibition of cell fusion was observed 18 hr posttransfection.
b (///) 60% of nuclei are present in syncytia; (/) 20% of nuclei are present in syncytia; (0) no syncytia were seen.
Similarly, the 3F1B35 peptide caused a 10-fold reduction with positive surface fluorescence for PI2 antigen,
whereas the levels of cells expressing PI2 antigen onin PI3 virus titers (not shown). These results indicate that
the peptides strongly inhibit subsequent rounds of virus their surfaces increased by 24 and 48 hpi. In contrast,
in cells incubated with peptide 2F1B34, there was nomultiplication, presumably by preventing virus entry.
As another indication of a reduction in spread of virus increase in numbers of cells showing antigen expression
on the surface at 24 h or 48 hpi. These data indicate thatinfection under multiple cycle conditions, the effect of
the peptides on plaque size was determined. As shown in the presence of the F peptides, the infection process
remains limited to the cells initially infected by the inocu-in Fig. 5, when the longer PI2 F peptide was added to
the agar overlay after the initial 1-hr virus adsorption lum virus.
period, the plaque size was reduced from about 3 mm
in diameter in control cells to 1.5 mm in the presence of DISCUSSION
the 2F1B34 peptide. This result also indicates that the F
We have observed that peptides which contain a hep-
peptides can inhibit multiple cycle replication of the virus,
tad repeat B sequence in the F1 subunit are specific
thus restricting viral spread.
inhibitors of PI2- or PI3-induced membrane fusion. The
We also compared the distribution of infected cells by
high specificity of their inhibitory effect was shown by
surface immunofluorescence at intervals post infection
the finding that each peptide was only able to inhibit
at m.o.i. of 0.1 in the presence or absence of F peptides.
fusion by the virus with the same F protein sequence,
As shown in Fig. 6, at 18 hr postinfection (hpi), cultures
i.e., peptides derived from PI2F will inhibit fusion by PI2
infected with PI2 virus showed limited number of cells
virus but not PI3 virus and vice versa. The most active
peptides extended from the second heptad repeat to the
TABLE 3
Inhibition of Plaque Formation by the F Peptidesa
2F1B34 Plaque 3F1B35 Plaque
(mM) numberb (mM) numberb
0 50 0 45
0.5 46 0.5 38
1 37 1 25
2 30 2 18
4 21 4 12
8 17 8 10
16 8 16 6
a A series of two-fold dilutions of F peptides together with appropri-
ately diluted PI2 or PI3 virus were added to monolayers of Vero cells.
After 1 hr incubation at 377, the inoculum was removed and overlaidFIG. 3. Dose-dependent inhibition of cell fusion by F peptides. HeLa
T4 cells were infected with PI2 or PI3 virus at 377 for 1 hr and peptides with 2% white agar mixed at a 1:1 ratio with 21 DMEM containing 2%
FBS. Three days after overlaying, red agar mixed at a 1:1 ratio with 21were added after removal of the inoculum. Inhibition of cell fusion was
observed at 24 hr postinfection. Cell fusion was measured by polykar- DMEM containing 2% FBS was overlaid to stain the cells. Plaque num-
bers were counted 1 day after neutral red staining and recorded.yon formation and expressed as (number of nuclei in polykaryons/
number of total nuclei) 1 100. Cells were counted in five different fields b The plaque numbers are the averages of three determinations at
each peptide concentration.under a light microscope.
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FIG. 4. Inhibition of virus production by F peptides. HeLa T4 cells
were infected with PI2 virus at a m.o.i. of 0.1. After incubation at 377
for 1 hr, the inoculum was removed and 2.5% DMEM was added with
or without addition of 4 mM of the synthetic peptides 2F1B21 and
2F1B34. Released virus titers were determined by plaque assay 48 hr
postinfection.
beginning of the transmembrane domain (34 a.a. for PI2F
and 35 a.a. for PI3F). Moreover, the F peptides were
found to inhibit fusion by virus-infected cells as well as
with vaccinia-expressed F and HN proteins and were
also found to inhibit multiple cycle replication of the virus. FIG. 6. Inhibition of the spread of viral infection. Monolayers of HeLa
T4 cells were infected by PI2 virus at an m.o.i. of 0.1. At 18, 24, andSeveral reports have shown that synthetic peptides
48 hr postinfection, cells were washed with PBS and incubated withcorresponding to a predicted coiled-coil region of gp41
rabbit anti-PI2 serum followed by FITC- conjugated goat anti-rabbitof HIV-1 near the fusion peptide or the transmembrane
IgG. Cell surface fluorescence was examined with a Nikon Optiphot
domain have the potential to inhibit virus-induced cell microscope. PI2 represents cells infected with PI2 virus only, while PI2
fusion (Jiang et al., 1993a,b; Wild et al., 1992, 1994a). / 2F1B34 were incubated with 4 mM of peptide 2F1B34.
More recently studies of synthetic peptides correspond-
ing to a conserved heptad repeat domain in paramyxovi-
with the virus or with the cell membrane. Wild et al. (1995)rus F proteins also showed a potent inhibitory effect on
proposed that peptide DP-107 corresponding to the leu-virus-induced cell fusion (Rapaport et al., 1995; Lambert
cine zipper-like motif near the fusion peptide region func-et al., 1996). The mechanism by which these peptides
tions through interaction with the leucine zipper domaininhibit HIV-1- or paramyxovirus-induced cell fusion is not
of gp41 and disruption of its functional role in the processfully understand. The peptides could alternatively interact
of virus entry. Jiang et al. (1993a,b) proposed a different
inhibition mechanism, in which the peptides interact with
the N-terminal fusion domain of gp41, which disrupts
insertion of the fusogenic sequence into the target cell
membrane during virus entry. Rapaport et al. (1995) re-
ported that peptides from the Sendai virus (SN) F protein
located near the fusion peptide (similar to DP-107) did
not have an anti-viral effect, while peptides derived from
the leucine zipper-like region in the F protein adjacent to
the transmembrane anchor inhibited the fusion of Sendai
virus with human erythrocytes. Recent studies of pep-
tides from the conserved heptad repeat region of other
FIG. 5. Plaque size reduction by F peptides. Plaque assay was per- paramyxovirus fusion proteins, including respiratory syn-
formed on Vero cells using PI2 virus. After 1 hr at 377, inoculum was cytial virus (RSV), PI3, and measles virus (MV), also
removed and cells overlaid with a 1:1 mixture of 2% white agar with showed a potent inhibitory effect on viral fusion (Lambert
21 DMEM containing 2% FBS (A) without addition of F peptide or (B)
et al., 1996). Our results are consistent with the resultswith addition of 4 mM of 2F1B34 in the overlay agar. Three days after
reported by Lambert et al. (1996). Furthermore, we foundoverlaying, the agar was removed and the monolayer of cells was
stained with crystal violet. that the F peptides could also inhibit viral entry and multi-
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ple cycle replication. One possible mechanism for this effect on viral entry as well as the spread of infection
after low m.o.i inoculation. HIV or Sendai virus-derivedinhibitory effect could involve an interaction of the pep-
tides with the viral glycoproteins, affecting a conforma- peptides (Wild et al., 1994a; Rapaport et al., 1995) did
not interfere with the attachment of the virus to the targettional change in the F protein which may be required for
fusion. Alternatively, the peptides may block the specific cells, and we have made similar observations for PI2 and
PI3 peptides (data not shown). The F peptides thereforeinteraction of F and HN which is required for the fusion
process. However, it has not yet been established that appear to inhibit viral entry at a stage after viral attach-
ment, which is likely to be the fusion of the viral envelopethe peptides interact directly with the viral glycoproteins.
We found that the functional concentrations of the puri- with the cell membranes. In addition, we observed that
the F peptides interfere with fusion induced by the Ffied peptides were comparable with those reported by
others for HIV and paramyxoviruses (Wild et al., 1994a; and HN glycoproteins expressed using the vaccinia-T7
expression system. Although cell fusion could be com-Rapaport et al., 1995; Lambert et al., 1996). Peptide
3F1B35 corresponds to the PI3 peptide designated T- pletely inhibited by the F peptides at similar concentra-
tions, the F peptides did not completely block virus entry,210 by Lambert and co-workers. We found that 3F1B35
inhibited 50% of virus-induced cell fusion at a concentra- as seen in a plaque reduction assay. In addition, the
concentration of peptides required for 50% inhibition oftion of 1.2 mM (4.8 mg/ml), while in their assay T-210 was
reported to have an EC50 of 2.4 mg/ml. Furthermore, they fusion was somewhat lower than that required for 50%
inhibition of plaque formation in both PI2 and PI3 virus.compared a series of overlapping 35-amino-acid pep-
tides and reported that peptides containing additional The peptides therefore appear to be more effective inhibi-
tors of cell–cell fusion than fusion of the virus to the cell.amino acids at the N-terminal side of heptad repeat B
domain showed little or no activity, while peptides ex- Similarly, the HIV-1 peptide DP-178 which corresponds
to the leucine zipper-like motif near the N-terminus oftending to the C-terminal side showed more potent antivi-
ral activity. Similarly, we observed that peptides which the transmembrane domain was a more potent inhibitor
of cell–cell fusion than of infection by cell-free virus (Wildextend from the heptad repeat B to the beginning of the
transmembrane domain were more potent inhibitors of et al., 1994a). Although the reason for the difference in
potency of the peptides in these two processes is un-virus-induced cell fusion than a peptide corresponding to
the heptad repeat region only. Moreover, the F peptides clear, it may reflect differences in the processes of cell-
free virus transmission vs cell to cell fusion.derived from one virus could only inhibit cell fusion in-
duced by this specific virus but not others. Lambert and Many peptides have short half lives when adminis-
tered systemically. Because the F peptides are likely toco-workers (1996) also observed a high level of virus
specificity of the inhibitory peptides, although some PI3 be interacting with the external domains of the viral enve-
lope proteins, it is also likely that they could be actingpeptides were cross-reactive with respiratory syncytial
virus and measles virus. Although the length of the pep- at the surfaces of infected cells and thus could prevent
virus spread during multiple cycles of infection. It istides may be crucial to the inhibitory effect in both PI2
and PI3 viral-induced cell fusion, the specificity of pep- therefore possible that the F peptides would inhibit virus
infection when administered to the respiratory tract bytides for fusion by a specific paramyxovirus is presum-
ably related to differences in the F or HN sequences of aerosol. This may provide an approach for inhibiting virus
infection in vivo, which may lead to control of the seriousthese viruses. Sequence comparison of these regions
showed no sequence homology except for a common respiratory diseases in infants which result from parain-
fluenza virus infections.leucine zipper-like motif which has the potential to form
a coiled-coil secondary structure. Moreover, a chimeric
HN containing an 82-amino acid region derived from SN- ACKNOWLEDGMENTS
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